CN104173518B - The dizzy syndrome medicament of Meniere's and method for making - Google Patents
The dizzy syndrome medicament of Meniere's and method for making Download PDFInfo
- Publication number
- CN104173518B CN104173518B CN201410444126.8A CN201410444126A CN104173518B CN 104173518 B CN104173518 B CN 104173518B CN 201410444126 A CN201410444126 A CN 201410444126A CN 104173518 B CN104173518 B CN 104173518B
- Authority
- CN
- China
- Prior art keywords
- herba
- radix
- dizzy
- meniere
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 63
- 208000002173 dizziness Diseases 0.000 title claims abstract description 50
- 208000011580 syndromic disease Diseases 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 title description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 35
- 241000131808 Scolopendra Species 0.000 claims abstract description 19
- 241000522620 Scorpio Species 0.000 claims abstract description 19
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims abstract description 19
- 239000009490 scorpio Substances 0.000 claims abstract description 19
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 16
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 14
- 241000237636 Pheretima Species 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 36
- 239000000203 mixture Substances 0.000 abstract description 24
- 239000002552 dosage form Substances 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 239000000843 powder Substances 0.000 description 27
- 230000000694 effects Effects 0.000 description 24
- 208000009205 Tinnitus Diseases 0.000 description 20
- 210000004185 liver Anatomy 0.000 description 20
- 231100000886 tinnitus Toxicity 0.000 description 20
- 239000007788 liquid Substances 0.000 description 19
- 208000002193 Pain Diseases 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 208000024891 symptom Diseases 0.000 description 16
- 239000000796 flavoring agent Substances 0.000 description 14
- 235000019634 flavors Nutrition 0.000 description 14
- 230000036461 convulsion Effects 0.000 description 13
- 229940079593 drug Drugs 0.000 description 13
- 206010019233 Headaches Diseases 0.000 description 12
- 238000009835 boiling Methods 0.000 description 12
- 231100000869 headache Toxicity 0.000 description 12
- 206010010904 Convulsion Diseases 0.000 description 11
- 208000027530 Meniere disease Diseases 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 239000012567 medical material Substances 0.000 description 11
- 208000012886 Vertigo Diseases 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 230000001717 pathogenic effect Effects 0.000 description 10
- 231100000889 vertigo Toxicity 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 9
- 239000006187 pill Substances 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 206010011878 Deafness Diseases 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- SWZMSZQQJRKFBP-WZRBSPASSA-N Securinine Chemical compound N12CCCC[C@@H]2[C@@]23OC(=O)C=C2C=C[C@@H]1C3 SWZMSZQQJRKFBP-WZRBSPASSA-N 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 210000003128 head Anatomy 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010030302 Oliguria Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 235000021419 vinegar Nutrition 0.000 description 4
- 239000000052 vinegar Substances 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010019468 Hemiplegia Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 241000867909 Securinega Species 0.000 description 3
- SWZMSZQQJRKFBP-UHFFFAOYSA-N Vivosecurinine Natural products N12CCCCC2C23OC(=O)C=C2C=CC1C3 SWZMSZQQJRKFBP-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 231100000895 deafness Toxicity 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 210000003027 ear inner Anatomy 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000005242 forging Methods 0.000 description 3
- 208000016354 hearing loss disease Diseases 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 229950005774 securinine Drugs 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 230000001720 vestibular Effects 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000723353 Chrysanthemum Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 241000722949 Apocynum Species 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- NROOUNRRNXKDBP-UHFFFAOYSA-N Dihydrophyllochrysin Natural products N12CCCCC2C23OC(=O)C=C2CCC1C3 NROOUNRRNXKDBP-UHFFFAOYSA-N 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- YPWHZCPMOQGCDQ-UHFFFAOYSA-N Populnin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=CC(O)=CC=3)OC2=C1 YPWHZCPMOQGCDQ-UHFFFAOYSA-N 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- BPTBWJUHULRABF-UHFFFAOYSA-N Securinol C Natural products C12CCCCN2C2CC(O)C3=CC(=O)OC31C2 BPTBWJUHULRABF-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041956 Stasis syndrome Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010061373 Sudden Hearing Loss Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- ZKEKDTIKFVCKMW-UHFFFAOYSA-N Trifolin Natural products OCC1OC(Oc2cc(O)ccc2C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O ZKEKDTIKFVCKMW-UHFFFAOYSA-N 0.000 description 1
- OHLFUILALUNTGR-UHFFFAOYSA-N UNPD114673 Natural products N12CCCCC2C23OC(=O)C=C2CC(O)C1C3 OHLFUILALUNTGR-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- RAWGYCTZEBNSTP-UHFFFAOYSA-N aluminum potassium Chemical compound [Al].[K] RAWGYCTZEBNSTP-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000005634 blind loop syndrome Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 230000001544 dysphoric effect Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001667 episodic effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-DTGCRPNFSA-N kaempferol 3-O-beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-DTGCRPNFSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 206010029864 nystagmus Diseases 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229940075930 picrate Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- -1 silicates Mica Group Minerals Chemical class 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- SVHWKXNNRMAUAN-UHFFFAOYSA-N virosine B Natural products N12CCCCC2C23CC(O)C1CC2=CC(=O)O3 SVHWKXNNRMAUAN-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510611613.3A CN105125675A (en) | 2014-09-03 | 2014-09-03 | Application of medicine for treating Meniere's vertiginous syndrome |
CN201510611659.5A CN105125676A (en) | 2014-09-03 | 2014-09-03 | Medicine for treating Meniere's vertigo syndrome |
CN201510612037.4A CN105125678A (en) | 2014-09-03 | 2014-09-03 | Medicine for relieving meniere's vertigo syndrome |
CN201510612079.8A CN105168459A (en) | 2014-09-03 | 2014-09-03 | Medicine composition for treating Labyrinthine vertigo syndrome |
CN201410444126.8A CN104173518B (en) | 2014-09-03 | 2014-09-03 | The dizzy syndrome medicament of Meniere's and method for making |
CN201510612038.9A CN105168458A (en) | 2014-09-03 | 2014-09-03 | Medicine composition for treating Labyrinthine vertigo syndrome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410444126.8A CN104173518B (en) | 2014-09-03 | 2014-09-03 | The dizzy syndrome medicament of Meniere's and method for making |
Related Child Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510611613.3A Division CN105125675A (en) | 2014-09-03 | 2014-09-03 | Application of medicine for treating Meniere's vertiginous syndrome |
CN201510612038.9A Division CN105168458A (en) | 2014-09-03 | 2014-09-03 | Medicine composition for treating Labyrinthine vertigo syndrome |
CN201510612037.4A Division CN105125678A (en) | 2014-09-03 | 2014-09-03 | Medicine for relieving meniere's vertigo syndrome |
CN201510612079.8A Division CN105168459A (en) | 2014-09-03 | 2014-09-03 | Medicine composition for treating Labyrinthine vertigo syndrome |
CN201510611659.5A Division CN105125676A (en) | 2014-09-03 | 2014-09-03 | Medicine for treating Meniere's vertigo syndrome |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104173518A CN104173518A (en) | 2014-12-03 |
CN104173518B true CN104173518B (en) | 2016-03-23 |
Family
ID=51955042
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510611613.3A Pending CN105125675A (en) | 2014-09-03 | 2014-09-03 | Application of medicine for treating Meniere's vertiginous syndrome |
CN201510612079.8A Pending CN105168459A (en) | 2014-09-03 | 2014-09-03 | Medicine composition for treating Labyrinthine vertigo syndrome |
CN201410444126.8A Active CN104173518B (en) | 2014-09-03 | 2014-09-03 | The dizzy syndrome medicament of Meniere's and method for making |
CN201510612038.9A Pending CN105168458A (en) | 2014-09-03 | 2014-09-03 | Medicine composition for treating Labyrinthine vertigo syndrome |
CN201510612037.4A Pending CN105125678A (en) | 2014-09-03 | 2014-09-03 | Medicine for relieving meniere's vertigo syndrome |
CN201510611659.5A Pending CN105125676A (en) | 2014-09-03 | 2014-09-03 | Medicine for treating Meniere's vertigo syndrome |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510611613.3A Pending CN105125675A (en) | 2014-09-03 | 2014-09-03 | Application of medicine for treating Meniere's vertiginous syndrome |
CN201510612079.8A Pending CN105168459A (en) | 2014-09-03 | 2014-09-03 | Medicine composition for treating Labyrinthine vertigo syndrome |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510612038.9A Pending CN105168458A (en) | 2014-09-03 | 2014-09-03 | Medicine composition for treating Labyrinthine vertigo syndrome |
CN201510612037.4A Pending CN105125678A (en) | 2014-09-03 | 2014-09-03 | Medicine for relieving meniere's vertigo syndrome |
CN201510611659.5A Pending CN105125676A (en) | 2014-09-03 | 2014-09-03 | Medicine for treating Meniere's vertigo syndrome |
Country Status (1)
Country | Link |
---|---|
CN (6) | CN105125675A (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1175445A (en) * | 1997-07-10 | 1998-03-11 | 迟经惠 | Brain refreshing pill for dizziness |
CN102225160B (en) * | 2011-06-15 | 2015-01-21 | 张明兰 | Traditional Chinese preparation for treating Menieres disease |
US9522873B2 (en) * | 2011-08-05 | 2016-12-20 | Dongguk University Industry-Academic Cooperation Foundation | Biphenyl derivative, pharmaceutically acceptable salt thereof, and methods for preventing or treating inflammatory diseases or autoimmune diseases |
CN102671052B (en) * | 2012-05-24 | 2013-07-24 | 张黎明 | Chinese medicinal composition for treating Meniere's syndrome |
CN103784851B (en) * | 2014-02-16 | 2016-03-16 | 董娟 | A kind of Chinese medicine preparation and preparation method for the treatment of Menieres disease |
CN103830552A (en) * | 2014-02-24 | 2014-06-04 | 王学峰 | Traditional Chinese medicine composition for treating Meniere's disease |
-
2014
- 2014-09-03 CN CN201510611613.3A patent/CN105125675A/en active Pending
- 2014-09-03 CN CN201510612079.8A patent/CN105168459A/en active Pending
- 2014-09-03 CN CN201410444126.8A patent/CN104173518B/en active Active
- 2014-09-03 CN CN201510612038.9A patent/CN105168458A/en active Pending
- 2014-09-03 CN CN201510612037.4A patent/CN105125678A/en active Pending
- 2014-09-03 CN CN201510611659.5A patent/CN105125676A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN105168459A (en) | 2015-12-23 |
CN105125678A (en) | 2015-12-09 |
CN104173518A (en) | 2014-12-03 |
CN105125675A (en) | 2015-12-09 |
CN105125676A (en) | 2015-12-09 |
CN105168458A (en) | 2015-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102727689B (en) | Traditional Chinese herbal composition for treating vertigo, preparation and method for preparing traditional Chinese herbal composition | |
CN104784624A (en) | Traditional Chinese medicine for treating dyspepsia | |
CN104173517B (en) | The Chinese medicine preparation for the treatment of primary trigeminal neuralgia and preparation method | |
CN104173773A (en) | Preparation with functions of treating migraine, dispelling wind and promoting blood circulation and preparation methods | |
CN103816417A (en) | Traditional Chinese medicine composition for treating infantile convulsion and preparation method thereof | |
CN103816454B (en) | One treats arteriosclerotic pure Chinese medicine capsule | |
CN102631655B (en) | Medicine for treating coronary heart disease and preparation method for medicine | |
CN105381424A (en) | Traditional Chinese medicine for detoxifying human viscera and preparation method of traditional Chinese medicine | |
CN104491596A (en) | Traditional Chinese medicine composition for treating liver-kidney yin deficiency type stroke and application thereof | |
CN107335019A (en) | It is a kind of be used to treat just, the pill medicine of antimigraine and preparation method thereof | |
CN104173518B (en) | The dizzy syndrome medicament of Meniere's and method for making | |
CN105770796A (en) | Medicinal liquor liniment for treating soft tissue injury | |
CN104800610A (en) | Traditional Chinese medicine preparation for treating Parkinson's disease and preparation method thereof | |
CN104173775A (en) | Traditional Chinese medicine composition for treating cervicogenic headache and preparation method of traditional Chinese medicine composition | |
CN103705733A (en) | Chinese medicine capsule for treating arrhythmia and preparation method thereof | |
CN105749047A (en) | Traditional Chinese medicine composition for treating simple goiter | |
CN105832934A (en) | Traditional Chinese medicine for treating hypertension | |
CN104547431A (en) | Traditional Chinese medicine tablet for relieving cerebral infarction sequela and preparation method of traditional Chinese medicine tablet | |
CN104173646A (en) | Traditional Chinese medicine decoction for treating dizziness caused by qi-blood deficiency and preparation method thereof | |
CN104288396A (en) | Traditional Chinese medicine decoction for treating senile dementia | |
CN104435176B (en) | Soothing the liver medicament and the preparation method of expelling the heat-evil of stamp hypertension on liver-heat | |
CN104042872A (en) | Traditional Chinese medicine composition for treating common cold of children and preparation method thereof | |
CN103638188A (en) | Chinese medicine for preventing and treating chronic osteomyelitis and preparation method thereof | |
CN102406789A (en) | Plaster for treating cervical spondylosis | |
CN108619452A (en) | It a kind of Chinese medicine composition that treating tumour and follows through permeabilization therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Guifang Inventor after: Pan Yuxian Inventor before: Zhang Shiyuan |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160215 Address after: 251900 family planning and maternal and child health care service station, Haifeng street, Wudi County, Binzhou, Shandong Applicant after: Liu Guifang Address before: 250000 Ji'nan Province Flyover District, Tuen Mun Road Sunshine District Applicant before: Zhang Shiyuan |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170811 Address after: Ding Yan Zhen Ding new road in Rugao city of Jiangsu province Nantong City, No. 30, 226500 Patentee after: Rugao Tianji hospital Address before: 251900 family planning and maternal and child health care service station, Haifeng street, Wudi County, Binzhou, Shandong Patentee before: Liu Guifang |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191118 Address after: 314100 Building 9, Guantang Road, Huimin street, Jiashan County, Jiaxing City, Zhejiang Province Patentee after: Jiashan Zhengfeng Electronic Factory Address before: 226500 No. 30 Dingxin Middle Road, Dingyan Town, Rugao City, Nantong City, Jiangsu Province Patentee before: Rugao Tianji hospital |